NEW YORK (GenomeWeb) – GeneNews today said that it will receive total proceeds of roughly C$1.4 million (US$1.1 million) from the exercise of warrants.

The Canadian molecular diagnostics firm said that 5,736,916 share purchase warrants, exercisable into around 1 million shares of common stock have been exercised. The exercise price was C$1.44.

GeneNews didn't disclose its intended use for the proceeds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.